Pericytes Derived from Human Pluripotent Stem Cells

  • John Jamieson
  • Bria Macklin
  • Sharon GerechtEmail author
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1109)


Pericytes wrap blood microvessels and are believed to play important roles in vascular morphogenesis, maturation, and stability. In addition, pericytes have emerged as candidates for targeting cancer growth and for wound healing. In order to model these processes and test new therapies, it is desirable to have a reliable, scalable source of pericytes. Human pluripotent stem cells (hPSCs), which possess the ability to differentiate into any cell type in the body, have been used to generate pericytes in vitro quickly, consistently, and with high yields. In this chapter, we consider the differentiation of pericytes from hPSCs. We compare the approaches taken by multiple groups and discuss characterization of hPSC-pericytes. Studying pericyte differentiation in vitro provides the opportunity to identify factors influencing pericyte development and to establish the ontogenic relationships between pericytes and similar cells. The development of highly specific, defined pericyte populations from hPSCs will enable downstream applications requiring large quantities of cells, including tissue engineered models and cell therapies.


Pericytes Pluripotent stem cells Differentiation In vitro Development Vasculature Embryoid body Mural cells Tissue engineering Specification Protocol Biomarkers 


  1. 1.
    Thomson JA et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147CrossRefGoogle Scholar
  2. 2.
    Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676. Scholar
  3. 3.
    Kim K et al (2010) Epigenetic memory in induced pluripotent stem cells. Nature 467:285–290. Scholar
  4. 4.
    Yamada M et al (2014) Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells. Nature 510:533–536. Scholar
  5. 5.
    Tachibana M et al (2013) Human embryonic stem cells derived by somatic cell nuclear transfer. Cell 153:1228–1238. Scholar
  6. 6.
    Wolf DP et al (2017) Concise review: embryonic stem cells derived by somatic cell nuclear transfer: a horse in the race? Stem Cells 35:26–34. Scholar
  7. 7.
    Ma H et al (2014) Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature 511:177–183. Scholar
  8. 8.
    Johannesson B et al (2014) Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors. Cell Stem Cell 15:634–642. Scholar
  9. 9.
    Zhao M-T et al (2017) Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs. PNAS 114:E11111–E11120. Scholar
  10. 10.
    Boroujerdi A, Tigges U, Welser-Alves JV, Milner R (2014) Cerebral angiogenesis methods in molecular biology. Humana Press, New York, pp 383–392CrossRefGoogle Scholar
  11. 11.
    Jamieson JJ, Searson PC, Gerecht S (2017) Engineering the human blood-brain barrier in vitro. J Biol Eng 11:37. Scholar
  12. 12.
    Aday S, Cecchelli R, Hallier-Vanuxeem D, Dehouck MP, Ferreira L (2016) Stem cell-based human blood–brain barrier models for drug discovery and delivery. Trends Biotechnol 34:382–393. Scholar
  13. 13.
    Vatine GD et al (2017) Modeling psychomotor retardation using iPSCs from MCT8-deficient patients indicates a prominent role for the blood-brain barrier. Cell Stem Cell 20:831–843.e835. Scholar
  14. 14.
    Lim RG et al (2017) Huntington’s disease iPSC-derived brain microvascular endothelial cells reveal WNT-mediated angiogenic and blood-brain barrier deficits. Cell Rep 19:1365–1377. Scholar
  15. 15.
    Juopperi TA et al (2012) Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington’s disease patient cells. Mol Brain 5:17. Scholar
  16. 16.
    Shen EM, McCloskey KE (2017) Development of mural cells: from in vivo understanding to in vitro recapitulation. Stem Cells Dev 26:1020–1041. Scholar
  17. 17.
    Armulik A, Genové G, Betsholtz C (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21:193–215. Scholar
  18. 18.
    Sinha S, Santoro MM (2018) New models to study vascular mural cell embryonic origin: implications in vascular diseases. Cardiovasc Res 114(4):481–491. Scholar
  19. 19.
    Amos PJ et al (2008) IFATS collection: the role of human adipose-derived stromal cells in inflammatory microvascular remodeling and evidence of a perivascular phenotype. Stem Cells 26:2682–2690. Scholar
  20. 20.
    Klein D et al (2011) Vascular wall-resident CD44+ multipotent stem cells give rise to pericytes and smooth muscle cells and contribute to new vessel maturation. PLoS One 6:1–14. Scholar
  21. 21.
    Vidal M et al (2015) Adult DRG Stem/Progenitor Cells Generate Pericytes in the Presence of Central Nervous System (CNS) Developmental Cues, and Schwann Cells in Response to CNS Demyelination. Stem Cells 33:2011–2024. Scholar
  22. 22.
    Dar A et al (2012) Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb clinical perspective. Circulation 125:87–99. Scholar
  23. 23.
    Kusuma S et al (2013) Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix. PNAS 110:12601–12606. Scholar
  24. 24.
    Wanjare M, Kusuma S, Gerecht S (2014) Defining differences among perivascular cells derived from human pluripotent stem cells. Stem Cell Rep 2:561–575. Scholar
  25. 25.
    Orlova VV et al (2014) Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts significance. Arterioscler Thromb Vasc Biol 34:177–186. Scholar
  26. 26.
    Greenwood-Goodwin M, Yang J, Hassanipour M, Larocca D (2016) A novel lineage restricted, pericyte-like cell line isolated from human embryonic stem cells. Sci Rep 6:srep24403. Scholar
  27. 27.
    Kumar A et al (2017) Specification and diversification of pericytes and smooth muscle cells from mesenchymoangioblasts. Cell Rep 19:1902–1916. Scholar
  28. 28.
    Griffin C, Bajpai R (2017) Neural Crest-Derived Human Cranial Pericytes Model Primary Forebrain Pericytes and Predict Disease-Specific Cranial Vasculature Defects. Available at SSRN:
  29. 29.
    O’Rahilly R, Müller F (2010) Developmental stages in human embryos: revised and new measurements. CTO 192:73–84. Scholar
  30. 30.
    Tam PPL, Behringer RR (1997) Mouse gastrulation: the formation of a mammalian body plan. Mech Dev 68:3–25. Scholar
  31. 31.
    Sinha S, Iyer D, Granata A (2014) Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical application. Cell Mol Life Sci 71:2271–2288. Scholar
  32. 32.
    Mummery CL et al (2012) Differentiation of human ES and iPS cells to cardiomyocytes: a methods overview. Circ Res 111:344–358. Scholar
  33. 33.
    Geevarghese A, Herman IM (2014) Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies. Transl Res 163:296–306. Scholar
  34. 34.
    Bergers G, Song S (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro-Oncol 7:452–464. Scholar
  35. 35.
    Caplan AI (2008) All MSCs are pericytes? Cell Stem Cell 3:229–230. Scholar
  36. 36.
    Crisan M et al (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301–313. Scholar
  37. 37.
    Paul G et al (2012) The adult human brain harbors multipotent perivascular mesenchymal stem cells. PLoS One 7:e35577. Scholar
  38. 38.
    Dar A et al (2012) Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation 125:87–99. Scholar
  39. 39.
    Guimaraes-Camboa N et al (2017) Pericytes of multiple organs do not behave as mesenchymal stem cells in vivo. Cell Stem Cell 20:345–359 e345. Scholar
  40. 40.
    Kusuma S et al (2013) Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix. Proc Natl Acad Sci U S A 110:12601–12606. Scholar
  41. 41.
    Orlova VV et al (2014) Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells. Nat Protoc 9:1514–1531. Scholar
  42. 42.
    Greenwood-Goodwin M, Yang J, Hassanipour M, Larocca D (2016) A novel lineage restricted, pericyte-like cell line isolated from human embryonic stem cells. Sci Rep 6:24403. Scholar
  43. 43.
    Attwell D, Mishra A, Hall CN, O’Farrell FM, Dalkara T (2016) What is a pericyte? J Cereb Blood Flow Metab 36:451–455. Scholar
  44. 44.
    Hill RA et al (2015) Regional blood flow in the normal and ischemic brain is controlled by arteriolar smooth muscle cell contractility and not by capillary pericytes. Neuron 87:95–110. Scholar
  45. 45.
    Birbrair A et al (2014) Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner. Stem Cell Res Ther 5:122. Scholar
  46. 46.
    Dias Moura Prazeres PH et al (2017) Pericytes are heterogeneous in their origin within the same tissue. Dev Biol 427:6–11. Scholar
  47. 47.
    Dore-Duffy P (2008) Pericytes: pluripotent cells of the blood brain barrier. Curr Pharm Des 14:1581–1593. Scholar
  48. 48.
    Wanjare M, Kuo F, Gerecht S (2013) Derivation and maturation of synthetic and contractile vascular smooth muscle cells from human pluripotent stem cells. Cardiovasc Res 97:321–330. Scholar
  49. 49.
    Bajpai VK, Mistriotis P, Loh Y-H, Daley GQ, Andreadis ST (2012) Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. Cardiovasc Res 96:391–400. Scholar
  50. 50.
    Etchevers HC, Vincent C, Douarin NML, Couly GF (2001) The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development 128:1059–1068PubMedPubMedCentralGoogle Scholar
  51. 51.
    Korn J, Christ B, Kurz H (2002) Neuroectodermal origin of brain pericytes and vascular smooth muscle cells. J Comp Neurol 442:78–88. Scholar
  52. 52.
    Cheung C, Bernardo AS, Pedersen RA, Sinha S (2014) Directed differentiation of embryonic origin–specific vascular smooth muscle subtypes from human pluripotent stem cells. Nat Protocol 9:929–938. Scholar
  53. 53.
    Cheung C, Bernardo AS, Trotter MWB, Pedersen RA, Sinha S (2012) Generation of human vascular smooth muscle subtypes provides insight into embryological origin–dependent disease susceptibility. Nat Biotech 30:165–173. Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.Department of Chemical and Biomolecular EngineeringInstitute for NanoBioTechnology, and the Physical Sciences-Oncology Center, Johns Hopkins UniversityBaltimoreUSA

Personalised recommendations